Drawing for AP ACTIMIS PHARMACEUTICALS

USPTO serial 78853453

AP ACTIMIS PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 3600352Status 710
Filing date
Status date
Registration date
Mar 31, 2009
Examiner
GOODSAID, IRA
Law office
TMEG LAW OFFICE 101

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AP ACTIMIS PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Paul Oleksiuk

John Paul Oleksiuk COOLEY LLP1299 Pennsylvania Avenue NW, Suite 700WASHINGTON, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disordersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2019CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 31, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 20, 2015NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 20, 2015C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 20, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 30, 2015E815TEAS SECTION 8 & 15 RECEIVED—
Oct 15, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 31, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 20, 2009REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Feb 20, 2009ALIEASSIGNED TO LIE—
Feb 12, 2009CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 11, 2009SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 9, 2009IUAFUSE AMENDMENT FILED—
Feb 9, 2009EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 21, 2008EX3GSOU EXTENSION 3 GRANTED—
Aug 21, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 12, 2008EXT3SOU EXTENSION 3 FILED—
Aug 12, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2008EX2GSOU EXTENSION 2 GRANTED—
Feb 10, 2008EXT2SOU EXTENSION 2 FILED—
Feb 10, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 17, 2007EX1GSOU EXTENSION 1 GRANTED—
Aug 13, 2007EXT1SOU EXTENSION 1 FILED—
Aug 13, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2007CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 31, 2007COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 13, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 21, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 1, 2006NPUBNOTICE OF PUBLICATION—
Sep 29, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 27, 2006ALIEASSIGNED TO LIE—
Sep 19, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2006XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2006GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 15, 2006DOCKASSIGNED TO EXAMINER—
Jul 10, 2006CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 10, 2006COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 7, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance